Ernesto Zecca

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Ernesto Zecca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

49 Article

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer
Shkodra, M., Brunelli, C., Zecca, E., Formaglio, F., Bracchi, P., Lo Dico, S., Caputo, M., Kaasa, S. & Caraceni, A., Mar 1 2021, In: Pain. 162, 3, p. 866-874 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways. Lung cancer (Amsterdam, Netherlands)
Caraceni, A., Lo Dico, S., Zecca, E., Brunelli, C., Bracchi, P., Mariani, L., Garassino, M. C. & Vitali, M., 2020, In: Lung Cancer. 139, p. 13-17 5 p.
Research output: Contribution to journal › Article › peer-review
Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial
Ricchini, F., Caraceni, A., Zecca, E., Pigni, A., Centurioni, F., Manzoni, A., Kaasa, S. & Brunelli, C., Oct 2019, In: Journal of Pain and Symptom Management. 58, 4, p. 587-595 9 p.
Research output: Contribution to journal › Article › peer-review
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)
Mercadante, S., Marchetti, P., Cuomo, A., Caraceni, A., Mediati, R. D., Mammucari, M., Natoli, S., Lazzari, M., Dauri, M., Airoldi, M., Azzarello, G., Bandera, M., Blasi, L., Cartenì, G., Chiurazzi, B., Costanzo, B. V. P., Degiovanni, D., Fusco, F., Guardamagna, V., Iaffaioli, V. & 150 others, Liguori, S., Lorusso, V., Mameli, S., Mattioli, R., Mazzei, T., Melotti, R. M., Menardo, V., Miotti, D., Moroso, S., De Santis, S., Orsetti, R., Papa, A., Ricci, S., Sabato, A. F., Scelzi, E., Sofia, M., Tonini, G., Aielli, F., Valle, A., Caruselli, A., Prestia, G., Giusti, R., Costanzi, A., Angelini, S., Iacono, D., Mazzuca, F., Carnevale, A., Bonome, P., Nicosia, L., Scaringi, C., Montalto, A., Russo, G., Forte, C. A., Esposito, G., Bracchi, P., Zecca, E., Campa, T., Grecchi, S., Pigni, A., Sammaro, A., Dodaro, L., Ballerini, G., Vellucci, R., Caldarulo, C., Palombo, E., Diviza, M., Gianfelice, V., Silvestri, C., Finocchi, S., Contu, V., Fora, G., Pedani, F., Icardi, M., Bellini, E., Celano, A., Berardo, R., Ostellino, O., Sartori, K., Demartini, P., Scroccaro, R., Boscolo, G., Sartori, D., Rosetti, F., Artioli, G., Borgato, L., Bertoldero, G., Veronese, B., Vallini, I., Tuzi, A., Bolzacchini, E., Pinotti, G., Alù, M., Usset, A., Arcuri, C., Laudani, A., Pepe, A., Scagliarini, S., Sgarlata, M. S. M., Raimondi, M., Valenti, S. M. G., Bucceri, A., Kasa, A., Budel, P., Caramellino, A., Ballarino, P., Donelli, E., Silvestro, S., Tonetti, R., Bozzoni, S., Cocquio, A., Romano, C., Nappi, A., Silvestro, L., De Divitiis, C., Ghidoni, S., Cortinovis, R., Marchesi, R., Fortis, M., Palermo, L., Pisanu, G. M., Carboni, M., Meloni, F., Barillari, D., Imperatori, L., Grilli, G., Laici, G., Diacciati, S., Petreni, P., Samolsky Dekel, B., Marsigli, F., Manfreda, M., Ghedini, S., Bruno, E., Salvini, E., Gerboni, D., Saulle, S., Carella, R., Pascoletti, G., Bolzonello, S., Bonotto, M., Ellero, S., Fasola, G., Ongaro, E., Borghesi, C., Germani, L., De Ruvo, E., Marchetti, F., Pasquale, M., Masu, L., Tammaro, D., Saracco, E., Di Dato, M. T., Ferrara, M., Pironti, A., Buonavolontà, P., Ginocchi, L., Musettini, G., Antonuzzo, A., Caparello, C., Lucchesi, M., Farnesi, A., Zampieri, M., Pisciotta, M., Fioroni, I., Ratta, R., Cursano, M. C., Santini, D., Potestà, C., Gallo, G. & Saber, B., 2017, In: Advances in Therapy. 34, 1, p. 120-135 16 p.
Research output: Contribution to journal › Article › peer-review
Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial.
Zecca, E., Brunelli, C., Centurioni, F., Manzoni, A., Pigni, A. & Caraceni, A., Mar 1 2017, In: Journal of Clinical Oncology. 35, 7, p. 759-765 7 p.
Research output: Contribution to journal › Article › peer-review

Ernesto Zecca

Fingerprint

Network

Dive into details

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways. Lung cancer (Amsterdam, Netherlands)

Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)

Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial.

Ernesto Zecca

Fingerprint

Network

Research output

Neuropathic pain: clinical classification and assessment in patients with pain due to cancer

Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways. Lung cancer (Amsterdam, Netherlands)

Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial

Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS)

Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial.